Atsushi Hirayama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Atsushi Hirayama has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Hisao Ogawa
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita 565-8565, Japan
1 shared publication - Junya Ako
Department of Cardiovascular Medicine, Kitasato University School of Medicine , Sagamihara
1 shared publication - Katsumi Miyauchi
Department of Cardiology, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan
1 shared publication - Kazuo Kimura
Division of Cardiology, Yokohama City University Medical Center
1 shared publication Kentaro Adachi
Cardiovascular Medicine, Osaka Police Hospital, Osaka, JPN
1 shared publication- Koichi Kaikita
Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
1 shared publication
Latest Publications
- Open Access
- 24 June 2022
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 86 (7) , 1204
JCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- 24 June 2022
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 86 (7) , 1204
Open AccessJCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- 26 October 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (17) , 1449-1451
Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial
- 26 October 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (17) , 1449-1451
Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial
- Open Access
- 9 April 2021
- Published by Springer Nature in Cureus
- Vol. 13 (4)
Idiopathic Effusive-Constrictive Pericarditis Presented by Variant Angina
An 80-year-old man presented to our hospital complaining of loss of appetite. During the medical examination, he developed variant angina accompanied with heart failure. Oral calcium channel blocker therapy controlled his variant angina, but medical management of heart failure became increasingly difficult due to gradually increasing pericardial effusion, and pericardiocentesis leading to the diagnosis of effusive-constrictive pericarditis (ECP). Here, we report a rare case of idiopathic pericarditis caused variant angina with already having endothelial dysfunction and eventually developed ECP.
- 9 April 2021
- Published by Springer Nature in Cureus
- Vol. 13 (4)
Open AccessIdiopathic Effusive-Constrictive Pericarditis Presented by Variant Angina
An 80-year-old man presented to our hospital complaining of loss of appetite. During the medical examination, he developed variant angina accompanied with heart failure. Oral calcium channel blocker therapy controlled his variant angina, but medical management of heart failure became increasingly difficult due to gradually increasing pericardial effusion, and pericardiocentesis leading to the diagnosis of effusive-constrictive pericarditis (ECP). Here, we report a rare case of idiopathic pericarditis caused variant angina with already having endothelial dysfunction and eventually developed ECP.